	As time goes by: Treatment challenges in elderly people with multiple sclerosis. J Neuroimmunol Gelibter S, Saraceno L, Pirro F, Susani EL, Protti A. PMID: 38761652 [PubMed - as supplied by publisher]
	Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms. J Neural Transm (Vienna) Jellinger KA. PMID: 38761183 [PubMed - as supplied by publisher]
	The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study. Iran J Immunol Jafari Harandi A, Mirzaee Sedigh A, Ataei M, Bayrami S, Esmaeilzadeh E, Sanati MH. PMID: 38761094 [PubMed - as supplied by publisher]
	Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals. Neurol Ther Shephard A, Kolaczkowski L, Barker N, Nahal D, Oreja-Guevara C, Reyes S, Gray H, Salloukh H, Giovannoni G. PMID: 38760637 [PubMed - as supplied by publisher]
	Relationship between event-related potentials and cognitive dysfunction in multiple sclerosis: A systematic review. Clin Neurophysiol Ferreira JA, Pinto N, Maricoto T, Pato MV. PMID: 38759513 [PubMed - as supplied by publisher]
	Diagnosis concealment behaviors and disclosure beliefs are associated with health and quality of life in people with multiple sclerosis. Mult Scler Relat Disord Leavitt VM, Bae C, Shinohara RT, Weinstein SM, Schmidt H, Aoun SM, Solari A, Solomon AJ. PMID: 38759425 [PubMed - as supplied by publisher]
	Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot study. Mult Scler Relat Disord Maghbooli Z, Shirvani A, Moghadasi AN, Varzandi T, Hamtaei Ghashti S, Sahraian MA. PMID: 38759424 [PubMed - as supplied by publisher]
	Estimating the Prevalence and Burden of Multiple Sclerosis in China Using the Global Burden of Disease Study: Challenges and Future Directions. Neurology Palladino R, Monasta L. PMID: 38759138 [PubMed - indexed for MEDLINE]
	Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From the Global Burden of Disease Study 2019. Neurology Zhang C, Liu W, Wang L, Wang F, Li J, Liu Z, Zhao Y, Zhou M, Yin P, Hao J. PMID: 38759127 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Mirabegron Add-on Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study. Clin Neuropharmacol Mut SE, Selcuk F, , Delibas S. PMID: 38758978 [PubMed - as supplied by publisher]
	Renal disease associated with multiple sclerosis: A narrative review. Medicine (Baltimore) Elendu C, Amaechi DC, Elendu TC, Ozigis MO, Adegbola MO, Adebayo MA, Afolabi OG. PMID: 38758897 [PubMed - indexed for MEDLINE]
	Autoantibody Profile Emerged Years Before Multiple Sclerosis Diagnosis. JAMA Harris E. PMID: 38758535 [PubMed - as supplied by publisher]
	Evaluation of optical coherence tomography findings in patients with multiple sclerosis and glaucoma. Int Ophthalmol Uctepe F, Orenc P, Gungel H, Emre Toprak U. PMID: 38758396 [PubMed - indexed for MEDLINE]
	Is increased activator protein 1 in cerebrospinal fluid as a potential biomarker that distinguishes idiopathic intracranial hypertension from multiple sclerosis? Bratisl Lek Listy Karabork S, Celik H, Dursun AD, Ankarali H, Turkoglu SA. PMID: 38757596 [PubMed - indexed for MEDLINE]
	Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial. J Neurol Neurosurg Psychiatry Rocca MA, Valsasina P, Romanò F, Tedone N, Amato MP, Brichetto G, Boccia VD, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell RA, Feys P, Freeman J, Inglese M, Meza C, Motl RW, Salter A, Sandroff BM, Feinstein A, Filippi M, Cogex Research Team. PMID: 38754979 [PubMed - as supplied by publisher]
	Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study. Eur Neurol K, Akbayir E, Erol R, Demir AS, Özkan Ya, Yilmaz V, Tuzun E, Turkoglu R. PMID: 38754397 [PubMed - as supplied by publisher]
	Carotid intima media thickness in multiple sclerosis: A CLSA study. Mult Scler Relat Disord Marrie RA, Patel R, Schaffer SA. PMID: 38754248 [PubMed - as supplied by publisher]
	"A second birthday"? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation-a qualitative interview study. Front Neurol Volz T, Sippel A, Fischbach F, Richter J, Willison AG, Häußler V, Heesen C. PMID: 38751886 [PubMed]
	Time to move past typical syndromes in the diagnosis of multiple sclerosis. Mult Scler Lebrun-Frenay C, Okuda DT. PMID: 38751237 [PubMed - as supplied by publisher]
	Multiple sclerosis presenting with paroxysmal symptoms: Patients at the limitations of current diagnostic criteria. Mult Scler Heward KD, Roy-Hewitson C, Solomon AJ. PMID: 38751226 [PubMed - as supplied by publisher]

Articles 1 - 20 / 39309

Page 1 of 1966



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy